Evaluation of multimodality therapy for synchronous liver metastases of gastric cancer

Hiroshi Sasaki, Motoki Ninomiya, Shuya Yano, Tatsuo Umeoka, Masao Harano, Hideki Aoki, Tadashi Onoda, Shigehiro Shiozaki, Satoshi Ohno, Kenji Higaki, Norihisa Takakura

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We evaluated the significance of multimodality therapy for cases of liver metastases of gastric cancer. Accumulated survival rate and median survival time were analyzed for twenty cases of such gastric cancer. Survival rates of H1+H2 group and hepatic resection (HR) group were higher than that of H3 group and non-HR group. MST of HR group and hepatic arterial infusion (HAI) group were longer than that of non-HR group and non-HAI group. Survival rate of HAI group was higher than that of non-HAI group among eleven cases of HR group. On the other hand, survival rate of HR group was higher than that of non-HR group among eleven cases of HAI group. These results suggested that HAI chemotherapy after hepatic resection for gastric cancer patients with synchronous liver metastasis would improve prognosis.

Original languageEnglish
Pages (from-to)1924-1926
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume31
Issue number11
Publication statusPublished - Oct 2004
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Evaluation of multimodality therapy for synchronous liver metastases of gastric cancer'. Together they form a unique fingerprint.

  • Cite this

    Sasaki, H., Ninomiya, M., Yano, S., Umeoka, T., Harano, M., Aoki, H., Onoda, T., Shiozaki, S., Ohno, S., Higaki, K., & Takakura, N. (2004). Evaluation of multimodality therapy for synchronous liver metastases of gastric cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 31(11), 1924-1926.